...vated receptor-gamma ，PPARγ）这个转录因子也已被暗示对于某些瘤（包含乳癌） 的形成中扮演著肿瘤抑制者（tumor suppressor）的角色 。
基于16个网页-相关网页
在少数情况下，医生可能会因为严重的医学问题比如肿瘤或致命感染而让移植受者停用免疫抑制药物。
In rare cases, a physician may stop a transplant recipient's immunosuppressive drugs because of a serious medical problem such as cancer or life-threatening infection.
实验室中以患乳腺癌的老鼠为试验对象，研究者发现联合用药可以抑制癌症干细胞，而癌症干细胞是肿瘤扩增的驱动因素。
In lab tests using mice with breast cancer, researchers found that the drug combination suppressed the cancer stem cells thought to drive tumor progression.
PTK787因其对肿瘤抑制的出色疗效、口服生物利用度高等特点而成为VEGF受体酪氨酸激酶抑制剂中的佼佼者。
PTK787 is the most promising VEGF receptor- tyrosine kinase inhibitor in pipeline because of its potency in tumor inhibition and oral bioavailability.
应用推荐